The popularity of various obesity management medications has increased significantly in recent years. According to a new analysis of more than 60,000 patients, some of these drugs are associated with more cardiovascular benefits than others.

Nearly 120 million adults in the United States have hypertension, and just 1 in 4 of them have it under control. Treatments remain limited outside of lifestyle changes and hypertensive medications that are not always effective.  

Mary E. Brunkow, PhD; Fred Ramsdell, PhD; and Shimon Sakaguchi, PhD, MD, will share the 2025 prize for research that has led to new treatments for autoimmune disease and cancer. 

Michael Minogue spent nearly two decades as the chairman, president and CEO of Abiomed, and now he is running to be the next governor of Massachusetts. 

New research suggests there may be a cardiovascular benefit to considering dual antiplatelet therapy for valve-in-valve TAVR patients.

The new contract was signed just ahead of the Oct. 20 deadline. The insurer and academic health system were in dispute over reimbursement rates. The exact terms of the new multi-year agreement are unknown. 

With a combination of ChatGPT, at-home diagnostic devices and smartphone apps, a growing number of patients are taking their health into their own hands. But experts warn there are risks.

If familial hypercholesterolemia is not detected and treated early, it can lead to premature heart attacks and heart disease in young patients.